Tag: Johnson and Johnson

All

FDA Limits Use of J&J Janssen COVID-19 Vaccine

The FDA limited authorized use of the J&J Janssen COVID-19 vaccine to certain individuals due to risk of thrombosis with thrombocytopenia syndrome.

J&J COVID-19 Vaccine 85% Effective against Hospitalizations
Delta Variant May Evade Vaccine Immunity
FDA Authorizes Moderna and Janssen Boosters
FDA Approves Rybrevant for Certain NSC Lung Cancer Patients
Canadian Drugmaker Wants to Make J&J Vaccines for Poor Nations
FDA and CDC Lift Pause on Johnson & Johnson COVID-19 Vaccine
US to Halt Johnson & Johnson Vaccine Over Unexplained Blood Clots

All

How Does the Johnson & Johnson Vaccine Compare to Other Coronavirus Vaccines?

Maureen Ferran, a virologist at the Rochester Institute of Technology, explains how this third authorized vaccine works and explores the differences between it and the Moderna and Pfizer–BioNTech vaccines that are already in use.

FDA Analysis Confirms J&J COVID-19 Vaccine Prevents Severe Disease
J&J Submit COVID-19 Vaccine for FDA Authorization
J&J Single-dose Vaccine 85% Effective Preventing Severe COVID-19
Delays Expected for Johnson & Johnson Vaccine
Johnson & Johnson Covid-19 Vaccine Research Paused Due to Illness in Subject
Johnson & Johnson Selects Lead COVID-19 Vaccine Candidate

All

Johnson & Johnson to Write-off $900M RSV Fail

Johnson & Johnson is scrapping its investigational therapy for respiratory syncytial virus (RSV) and human metapneumovirus to the tune of a $900 million tax write-off.

FDA Makes August a Big Month for Actelion

Tag: Johnson and Johnson

All

All

All

Sorry, No Posts Found